| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 129757 | Null | 0.0385613993886001 | -0.10203987 |
| NSC 13151 | Null | 0.0385613993886001 | 0.025795805 |
| NSC 135687 | 5.beta.-Bufa-20,22-dienolide, 14,15.beta.-epoxy-3.beta.,5-dihydroxy-, 3-acetate (8CI) | 0.0385613993886001 | -0.098688041 |
| NSC 163424 | 4-Quinazolinamine, 2-[2-(1-pyrrolidinylazo)phenyl]- | 0.0385613993886001 | -0.1103025 |
| NSC 173552 | L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate | 0.0385613993886001 | -0.12205701 |
| NSC 185065 | Hydrazinecarbothioamide, 2-[(5-hydroxy-2-pyridinyl)methylene]-N-(3-pyridinyl)- | 0.0385613993886001 | -0.15093784 |
| NSC 244404 | Null | 0.0385613993886001 | -0.12362144 |
| NSC 321491 | Null | 0.0385613993886001 | 0.12368768 |
| NSC 342610 | Null | 0.0385613993886001 | -0.055618259 |
| NSC 351521 | Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) | 0.0385613993886001 | -0.050923159 |